AT

Atomera Inc.

Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.

ATOM | NDAQ

Overview

Corporate Details

ISIN(s):
US04965B1008
LEI:
Country:
United States of America
Address:
N/A
Website:
atomera.com
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Atomera Inc. is a semiconductor materials and intellectual property (IP) licensing company that develops, commercializes, and licenses proprietary technologies for the semiconductor industry. The company's core offering is its patented Mears Silicon Technology (MST®), a quantum-engineered material designed to enhance transistors. MST improves semiconductor performance by enabling faster and more controlled electron movement and better diffusion control of dopants. This technology allows manufacturers to create chips with higher performance, lower power consumption, and increased density. Atomera targets markets including mobile/5G, Internet of Things (IoT), and infrastructure, with applications spanning logic and processors, memory (DRAM, SRAM), FinFETs, analog and power devices, and image sensors. The company supports its licensees with engineering services and simulation tools like MSTcad™.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Atomera Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Atomera Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.